Integrating artificial intelligence into lung cancer screening: a randomised controlled trial protocol
Introduction Lung cancer (LC) is the most common cause of cancer-related deaths worldwide. Its early detection can be achieved with a CT scan. Two large randomised trials proved the efficacy of low-dose CT (LDCT)-based lung cancer screening (LCS) in high-risk populations. The decrease in specific mo...
Similar Items
-
Lung Cancer Screening, towards a Multidimensional Approach: Why and How?
by: Jonathan Benzaquen, et al.
Published: (2019-02-01) -
Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)
by: Paul Hofman, et al.
Published: (2022-01-01) -
Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
by: Nina Pujol, et al.
Published: (2022-10-01) -
Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
by: Simon Heeke, et al.
Published: (2018-03-01) -
Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
by: Marius Ilié, et al.
Published: (2023-02-01)